Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide.
about
Efficacy and limitations of cyclophosphamide-induced tolerance against alphaGal antigen.Sequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.Application of cyclophosphamide-induced tolerance in alpha1,3-galactosyltransferase knockout mice presensitized with Gal alpha 1-3Gal beta-4-GlcNAc antigens.Acquisition and presentation of follicular dendritic cell-bound antigen by lymph node-resident dendritic cellsComparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphomaBlockage of the macrophage migration inhibitory factor expression by short interference RNA inhibited the rejection of an allogeneic tracheal graft.Toward minimal conditioning protocols for allogeneic chimerism in tolerance resistant recipients.Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use.Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers.Myeloid Conditioning with c-kit-Targeted CAR-T Cells Enables Donor Stem Cell Engraftment.
P2860
Q33223831-AABCE86C-9212-4752-9B15-C561146CC0B1Q33246284-6513D5ED-A958-4A33-BD1F-75CECE99147AQ33364163-8BAA3FD5-4BFF-4C9A-A30D-C90E2931520DQ34501458-D8BB7A92-B8B6-4D20-9CF7-BBB8F72E698AQ37108595-A4BD4DEA-2670-44FD-96A4-6FD61821168BQ38321082-2D5BA7B3-2931-4A1F-9D4C-B1F6CC19018EQ40729942-0A395728-85AE-440B-9630-DE836FD7B1C2Q42507739-769F3BEC-3258-43DA-8737-B280998B14DFQ44050407-6621163B-A80F-44EE-950B-3E72B9127480Q44483603-133F0A28-E2A6-4CB4-8C2F-94B9DBE13260Q52603959-2006841D-D89D-4458-B863-4E4BD645EB26
P2860
Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Induction of permanent mixed c ...... followed by cyclophosphamide.
@en
Induction of permanent mixed c ...... followed by cyclophosphamide.
@nl
type
label
Induction of permanent mixed c ...... followed by cyclophosphamide.
@en
Induction of permanent mixed c ...... followed by cyclophosphamide.
@nl
prefLabel
Induction of permanent mixed c ...... followed by cyclophosphamide.
@en
Induction of permanent mixed c ...... followed by cyclophosphamide.
@nl
P2093
P1476
Induction of permanent mixed c ...... followed by cyclophosphamide.
@en
P2093
Yoshikawa M
P356
10.4049/JIMMUNOL.165.1.34
P407
P577
2000-07-01T00:00:00Z